Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Hull currently holds 977 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Hull has been a net buyer of INM stock. They have purchased $14.6K and sold $0 worth of shares.
Andrew Hull's most recent insider trade was on Dec 20, 2024, when they sold 550 shares at $0.00 per share.
Andrew Hull serves as Executive at InMed Pharmaceuticals Inc. (INM). They have executed 3 insider transactions totaling $14.6K over their tenure at the company.
Andrew Hull holds the position of Executive at InMed Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Andrew Hull has shown a buying trading pattern, with $14.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Hull was on Feb 21, 2024, when they purchased $14.6K worth of INM shares. This transaction involved 37,500 shares at $0.39 per share.
Andrew Hull currently owns 977 shares of InMed Pharmaceuticals Inc. (INM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Hull's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Hull has 3 Form 4 filings on record as an insider at InMed Pharmaceuticals Inc..
Set alerts for Andrew Hull and 40,000+ other insiders.